Formulation and Delivery
Naoki Yamada, MS
Director of Strategy & Operation
FUJIFILM Pharmaceutical U.S.A., Inc.
Cambridge, Massachusetts
Description: The potential capability of liposome formulation in advanced cancer therapies will be illustrated in this session. In particular, we will share preclinical results that liposome formulations can enhance the synergistic effect of chemo with ICI by stimulating cancer immunity. In addition, the challenges in early stage development from bench top to 1st in human of liposome formulations: species difference and CMC, and solutions will be presented and discussed.